羚锐制药董事陈燕拟减持不超20万股公司股份

Core Viewpoint - The announcement from Lingrui Pharmaceutical indicates that the company's Vice President Chen Yan plans to reduce his shareholding due to personal financial needs, which may impact investor sentiment and stock performance [1] Summary by Relevant Sections - Shareholding Reduction Plan - Chen Yan intends to sell up to 200,000 shares, which represents 0.0353% of the company's total share capital and up to 25% of his total holdings [1] - Current Shareholding Status - As of the announcement date, Chen Yan holds 965,000 shares, accounting for 0.17% of the company's total share capital [1]